Time To Shop? SK Sees ‘Biggest Opportunity’ For Biotech Investment
PROTAC, Antibodies, CGT, AI/Digital Technology All Eyed
At a recent forum in Seoul, SK Group unveiled its biotech investment strategy and noted the next few years could present multiple major opportunities for Korean biotechs.